Mangoceuticals (MGRX) closed at $0.28 on October 19, 2026, down 3.4% from the previous close, on volume of 730,919 shares (30-day average 588,623).
Data as of October 19, 2026.
Mangoceuticals Closes Registered Direct Offering Priced at 74% Premium to Recent Market Close
Globe Newswire (Fri, 9-Oct 4:01 PM ET)
Globe Newswire (Thu, 1-Oct 3:50 PM ET)
Business Wire (Mon, 17-Aug 9:18 AM ET)
Newsfile (Thu, 13-Aug 4:05 PM ET)
Globe Newswire (Thu, 13-Aug 4:05 PM ET)
Market Chameleon (Thu, 6-Aug 6:31 AM ET)
Newsfile (Thu, 6-Aug 7:04 AM ET)
Globe Newswire (Thu, 6-Aug 7:00 AM ET)
Nuclea Energy USA Inc. Announces MOU with Utah Office of Energy Development
Newsfile (Wed, 5-Aug 4:05 PM ET)
Globe Newswire (Wed, 5-Aug 4:05 PM ET)
Mangoceuticals Inc focuses on developing, marketing, and selling a variety of men's wellness products and services through a telemedicine platform. The company's platform provides access for customers to a licensed pharmacy for online fulfillment and distribution of certain medications that may be prescribed as part of telehealth consultations, including Mango ED products.
Mangoceuticals trades on the NASDAQ stock market under the symbol MGRX.
As of October 19, 2026, MGRX stock price declined to $0.28 with 730,919 million shares trading.
MGRX has a beta of 0.69, meaning it tends to be less sensitive to market movements. MGRX has a correlation of 0.00 to the broad based SPY ETF.
MGRX has a market cap of $6.04 million. This is considered a Sub-Micro Cap stock.
In the last 3 years, MGRX traded as high as $16.80 and as low as $.16.
The top ETF exchange traded funds that MGRX belongs to (by Net Assets): VXF.
MGRX has underperformed the market in the last year with a price return of -88.6% while the SPY ETF gained +17.2%. MGRX has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -27.9% and -35.9%, respectively, while the SPY returned +2.4% and -0.4%, respectively.
MGRX support price is $.27 and resistance is $.32 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that MGRX shares will trade within this expected range on the day.
